Levrero, M. Viral hepatitis and liver cancer: The case of hepatitis C. Oncogene 2006, 25, 3834-3847.
Pawlotsky, J. M. New hepatitis C therapies: The toolbox, strategies, and challenges. Gastroenterology 2014, 146, 1176-1192.
Dienes, H. P.; Popper, H.; Arnold, W.; Lobeck, H. Histologic observations in human hepatitis non-A, non-B. Hepatology 1982, 2, 562-571.
Schaefer, E. A.; Chung, R. T. HCV and host lipids: An intimate connection. Semin. Liver Dis. 2013, 33, 358-368.
Goossens, N.; Negro, F. Is genotype 3 of the hepatitis C virus the new villain? Hepatology 2014, 59, 2403-2412.
Corey, K. E.; Kane, E.; Munroe, C.; Barlow, L. L.; Zheng, H.; Chung, R. T. Hepatitis C virus infection and its clearance alter circulating lipids: Implications for long-term follow-up. Hepatology 2009, 50, 1030-1037.
Andre, P.; Komurian-Pradel, F.; Deforges, S.; Perret, M.; Berland, J. L.; Sodoyer, M.; Pol, S.; Brechot, C.; Paranhos-Baccala, G.; Lotteau, V. Characterization of low-and very-low-density hepatitis C virus RNA-containing particles. J. Virol. 2002, 76, 6919-6928.
Jones, C. T.; Murray, C. L.; Eastman, D. K.; Tassello, J.; Rice, C. M. Hepatitis C virus p7 and NS2 proteins are essential for production of infectious virus. J. Virol. 2007, 81, 8374-8383.
Moradpour, D.; Penin, F.; Rice, C. M. Replication of hepatitis C virus. Nat. Rev. MicroBiol. 2007, 5, 453-463.
Lindenbach, B. D.; Evans, M. J.; Syder, A. J.; Wolk, B.; Tellinghuisen, T. L.; Liu, C. C.; Maruyama, T.; Hynes, R. O.; Burton, D. R.; McKeating, J. A.; et al. Complete replication of hepatitis C virus in cell culture. Science 2005, 309, 623-626.
Wakita, T.; Pietschmann, T.; Kato, T.; Date, T.; Miyamoto, M.; Zhao, Z.; Murthy, K.; Habermann, A.; Krausslich, H. G.; Mizokami, M.; et al. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat. Med. 2005, 11, 791-796.
Zhong, J.; Gastaminza, P.; Cheng, G.; Kapadia, S.; Kato, T.; Burton, D. R.; Wieland, S. F.; Uprichard, S. L.; Wakita, T.; Chisari, F. V. Robust hepatitis C virus infection in vitro. Proc. Natl. Acad. Sci. USA 2005, 102, 9294-9299.
Pumeechockchai, W.; Bevitt, D.; Agarwal, K.; Petropoulou, T.; Langer, B. C.; Belohradsky, B.; Bassendine, M. F.; Toms, G. L. Hepatitis C virus particles of different density in the blood of chronically infected immunocompetent and immunodeficient patients: Implications for virus clearance by antibody. J. Med. Virol. 2002, 68, 335-342.
Bradley, D.; McCaustland, K.; Krawczynski, K.; Spelbring, J.; Humphrey, C.; Cook, E. H. Hepatitis C virus: Buoyant density of the factor VIII-derived isolate in sucrose. J. Med. Virol. 1991, 34, 206-208.
Felmlee, D. J.; Sheridan, D. A.; Bridge, S. H.; Nielsen, S. U.; Milne, R. W.; Packard, C. J.; Caslake, M. J.; McLauchlan, J.; Toms, G. L.; Neely, R. D.; et al. Intravascular transfer contributes to postprandial increase in numbers of very-low-density hepatitis C virus particles. Gastroenterology 2010, 139, doi: 10. 1053/j. gastro. 2010. 07. 047.
Nielsen, S. U.; Bassendine, M. F.; Burt, A. D.; Martin, C.; Pumeechockchai, W.; Toms, G. L. Association between hepatitis C virus and very-low-density lipoprotein (VLDL)/LDL analyzed in iodixanol density gradients. J. Virol. 2006, 80, 2418-2428.
Thomssen, R.; Bonk, S.; Propfe, C.; Heermann, K. H.; Kochel, H. G.; Uy, A. Association of hepatitis C virus in human sera with beta-lipoprotein. Med. Microbiol. Immunol. 1992, 181, 293-300.
Lindenbach, B. D.; Meuleman, P.; Ploss, A.; Vanwolleghem, T.; Syder, A. J.; McKeating, J. A.; Lanford, R. E.; Feinstone, S. M.; Major, M. E.; Leroux-Roels, G.; et al. Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro. Proc. Natl. Acad. Sci. USA 2006, 103, 3805-3809.
Catanese, M. T.; Uryu, K.; Kopp, M.; Edwards, T. J.; Andrus, L.; Rice, W. J.; Silvestry, M.; Kuhn, R. J.; Rice, C. M. Ultrastructural analysis of hepatitis C virus particles. Proc. Natl. Acad. Sci. USA 2013, 110, 9505-9510.
Chang, K. S.; Jiang, J.; Cai, Z.; Luo, G. Human apolipoprotein E is required for infectivity and production of hepatitis C virus in cell culture. J. Virol. 2007, 81, 13783-13793.
Gastaminza, P.; Cheng, G.; Wieland, S.; Zhong, J.; Liao, W.; Chisari, F. V. Cellular determinants of hepatitis C virus assembly, maturation, degradation, and secretion. J. Virol. 2008, 82, 2120-2129.
Meunier, J. C.; Russell, R. S.; Engle, R. E.; Faulk, K. N.; Purcell, R. H.; Emerson, S. U. Apolipoprotein C1 association with hepatitis C virus. J. Virol. 2008, 82, 9647-9656.
Sun, H. Y.; Lin, C. C.; Lee, J. C.; Wang, S. W.; Cheng, P. N.; Wu, I. C.; Chang, T. T.; Lai, M. D.; Shieh, D. B.; Young, K. C. Very low-density lipoprotein/lipo-viro particles reverse lipoprotein lipase-mediated inhibition of hepatitis C virus infection via apolipoprotein C-III. Gut 2012, 62, 1193-1203.
Merz, A.; Long, G.; Hiet, M. S.; Bruegger, B.; Chlanda, P.; Andre, P.; Wieland, F.; Krijnse-Locker, J.; Bartenschlager, R. Biochemical and morphological properties of hepatitis C virus particles and determination of their lipidome. J. Biol. Chem. 2011, 286, 3018-3032.
Tomiyasu, K.; Walsh, B. W.; Ikewaki, K.; Judge, H.; Sacks, F. M. Differential metabolism of human VLDL according to content of apoE and apoC-III. Arterioscler. Thromb. Vasc. Biol. 2001, 21, 1494-1500.
Jammart, B.; Michelet, M.; Pecheur, E. I.; Parent, R.; Bartosch, B.; Zoulim, F.; Durantel, D. Very-low-density lipoprotein (VLDL)-producing and hepatitis C virus-replicating HepG2 cells secrete no more lipoviroparticles than VLDL-deficient Huh7. 5 cells. J. Virol. 2013, 87, 5065-5080.
Vieyres, G.; Thomas, X.; Descamps, V.; Duverlie, G.; Patel, A. H.; Dubuisson, J. Characterization of the envelope glycoproteins associated with infectious hepatitis C virus. J. Virol. 2010, 84, 10159-10168.
Lindenbach, B. D. Virion assembly and release. Curr. Top. Microbiol. Immunol. 2013, 369, 199-218.
Bartenschlager, R.; Penin, F.; Lohmann, V.; Andre, P. Assembly of infectious hepatitis C virus particles. Trends MicroBiol. 2011, 19, 95-103.
Icard, V.; Diaz, O.; Scholtes, C.; Perrin-Cocon, L.; Ramiere, C.; Bartenschlager, R.; Penin, F.; Lotteau, V.; Andre, P. Secretion of hepatitis C virus envelope glycoproteins depends on assembly of apolipoprotein B positive lipoproteins. PLOS ONE 2009, 4, e4233.
Boyer, A.; Dumans, A.; Beaumont, E.; Etienne, L.; Roingeard, P.; Meunier, J. C. The association of hepatitis C virus glycoproteins with apolipoproteins E and B early in assembly is conserved in lipoviral particles. J. Biol. Chem. 2014, 289, 18904-18913.
Lee, J. Y.; Acosta, E. G.; Stoeck, I. K.; Long, G.; Hiet, M. S.; Mueller, B.; Fackler, O. T.; Kallis, S.; Bartenschlager, R. Apolipoprotein E likely contributes to a maturation step of infectious hepatitis C virus particles and interacts with viral envelope glycoproteins. J. Virol. 2014, 88, 12422-12437.
Dao Thi, V. L.; Granier, C.; Zeisel, M. B.; Guerin, M.; Mancip, J.; Granio, O.; Penin, F.; Lavillette, D.; Bartenschlager, R.; Baumert, T. F.; et al. Characterization of hepatitis C virus particle subpopulations reveals multiple usage of the scavenger receptor BI for entry steps. J. Biol. Chem. 2012, 287, 31242-31257.
Bartosch, B.; Dubuisson, J.; Cosset, F. L. Infectious hepatitis C pseudo-particles containing functional E1E2 envelope protein complexes. J. Exp. Med. 2003, 197, 633-642.
Drummer, H. E.; Maerz, A.; Poumbourios, P. Cell surface expression of functional hepatitis C virus E1 and E2 glycoproteins. FEBS Lett. 2003, 546, 385-390.
Hsu, M.; Zhang, J.; Flint, M.; Logvinoff, C.; Cheng-Mayer, C.; Rice, C. M.; McKeating, J. A. Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles. Proc. Natl. Acad. Sci. USA 2003, 100, 7271-7276.
Koutsoudakis, G.; Kaul, A.; Steinmann, E.; Kallis, S.; Lohmann, V.; Pietschmann, T.; Bartenschlager, R. Characterization of the early steps of hepatitis C virus infection by using luciferase reporter viruses. J. Virol. 2006, 80, 5308-5320.
Shi, Q.; Jiang, J.; Luo, G. Syndecan-1 serves as the major receptor for attachment of hepatitis C virus to the surfaces of hepatocytes. J. Virol. 2013, 87, 6866-6875.
Lefevre, M.; Felmlee, D. J.; Parnot, M.; Baumert, T. F.; Schuster, C. Syndecan 4 is involved in mediating HCV entry through interaction with lipoviral particle-associated apolipoprotein E. PLOS ONE 2014, 9, e95550.
Barth, H.; Schafer, C.; Adah, M. I.; Zhang, F.; Linhardt, R. J.; Toyoda, H.; Kinoshita-Toyoda, A.; Toida, T.; Van Kuppevelt, T. H.; Depla, E.; et al. Cellular binding of hepatitis C virus envelope glycoprotein E2 requires cell surface heparan sulfate. J. Biol. Chem. 2003, 278, 41003-41012.
Jiang, J.; Luo, G. Apolipoprotein E but not B is required for the formation of infectious hepatitis C virus particles. J. Virol. 2009, 83, 12680-12691.
Jiang, J.; Cun, W.; Wu, X.; Shi, Q.; Tang, H.; Luo, G. Hepatitis C virus attachment mediated by apolipoprotein E binding to cell surface heparan sulfate. J. Virol. 2012, 86, 7256-7267.
Agnello, V.; Abel, G.; Elfahal, M.; Knight, G. B.; Zhang, Q.-X. Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor. Proc. Natl. Acad. Sci. USA 1999, 96, 12766-12771.
Molina, S.; Castet, V.; Fournier-Wirth, C.; Pichard-Garcia, L.; Avner, R.; Harats, D.; Roitelman, J.; Barbaras, R.; Graber, P.; Ghersa, P.; et al. The low-density lipoprotein receptor plays a role in the infection of primary human hepatocytes by hepatitis C virus. J. Hepatol. 2007, 46, 411-419.
Owen, D. M.; Huang, H.; Ye, J.; Gale, M., Jr. Apolipoprotein E on hepatitis C virion facilitates infection through interaction with low-density lipoprotein receptor. Virology 2009, 394, 99-108.
Albecka, A.; Belouzard, S.; de Beeck, A. O.; Descamps, V.; Goueslain, L.; Bertrand-Michel, J.; Terce, F.; Duverlie, G.; Rouille, Y.; Dubuisson, J. Role of low-density lipoprotein receptor in the hepatitis C virus life cycle. Hepatology 2012, 55, 998-1007.
Andreo, U.; Maillard, P.; Kalinina, O.; Walic, M.; Meurs, E.; Martinot, M.; Marcellin, P.; Budkowska, A. Lipoprotein lipase mediates hepatitis C virus (HCV) cell entry and inhibits HCV infection. Cell. MicroBiol. 2007, 9, 2445-2456.
Shimizu, Y.; Hishiki, T.; Sugiyama, K.; Ogawa, K.; Funami, K.; Kato, A.; Ohsaki, Y.; Fujimoto, T.; Takaku, H.; Shimotohno, K. Lipoprotein lipase and hepatic triglyceride lipase reduce the infectivity of hepatitis C virus (HCV) through their catalytic activities on HCV-associated lipoproteins. Virology 2010, 407, 152-159.
Shen, W. J.; Hu, J.; Hu, Z.; Kraemer, F. B.; Azhar, S. Scavenger receptor class B type I (SR-BI): A versatile receptor with multiple functions and actions. Metab. Clin. Exp. 2014, 63, 875-886.
Scarselli, E.; Ansuini, H.; Cerino, R.; Roccasecca, R. M.; Acali, S.; Filocamo, G.; Traboni, C.; Nicosia, A.; Cortese, R.; Vitelli, A. The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus. EMBO J. 2002, 21, 5017-5025.
Maillard, P.; Huby, T.; Andreo, U.; Moreau, M.; Chapman, J.; Budkowska, A. The interaction of natural hepatitis C virus with human scavenger receptor SR-BI/Cla1 is mediated by apoB-containing lipoproteins. FASEB J. 2006, 20, 735-737.
Dao Thi, V. L.; Dreux, M.; Cosset, F. L. Scavenger receptor class B type I and the hypervariable region-1 of hepatitis C virus in cell entry and neutralisation. Expert Rev. Mol. Med. 2011, 13, e13.
Zahid, M. N.; Turek, M.; Xiao, F.; Thi, V. L.; Guerin, M.; Fofana, I.; Bachellier, P.; Thompson, J.; Delang, L.; Neyts, J.; et al. The postbinding activity of scavenger receptor class B type I mediates initiation of hepatitis C virus infection and viral dissemination. Hepatology 2013, 57, 492-504.
Bartosch, B.; Verney, G.; Dreux, M.; Donot, P.; Morice, Y.; Penin, F.; Pawlotsky, J. M.; Lavillette, D.; Cosset, F. L. An interplay between the hyper-variable region 1 of the HCV E2 glycoprotein, the scavenger receptor BI and HDL promotes both enhancement of infection and protection against neutralizing antibodies. J. Virol. 2005, 79, 8217-8229.
Meunier, J. C.; Engle, R. E.; Faulk, K.; Zhao, M.; Bartosch, B.; Alter, H.; Emerson, S. U.; Cosset, F. L.; Purcell, R. H.; Bukh, J. Evidence for cross-genotype neutralization of hepatitis C virus pseudo-particles and enhancement of infectivity by apolipoprotein C1. Proc. Natl. Acad. Sci. USA 2005, 102, 4560-4565.
Voisset, C.; Callens, N.; Blanchard, E.; op de Beeck, A.; Dubuisson, J.; Vu-Dac, N. High density lipoproteins facilitate hepatitis C virus entry through the scavenger receptor class B type I. J. Biol. Chem. 2005, 280, 7793-7799.
Von Hahn, T.; Lindenbach, B. D.; Boullier, A.; Quehenberger, O.; Paulson, M.; Rice, C. M.; McKeating, J. A. Oxidized low-density lipoprotein inhibits hepatitis C virus cell entry in human hepatoma cells. Hepatology 2006, 43, 932-942.
Pileri, P.; Uematsu, Y.; Campagnoli, S.; Galli, G.; Falugi, F.; Petracca, R.; Weiner, A. J.; Houghton, M.; Rosa, D.; Grandi, G.; et al. Binding of hepatitis C virus to CD81. Science 1998, 282, 938-941.
Bankwitz, D.; Steinmann, E.; Bitzegeio, J.; Ciesek, S.; Friesland, M.; Herrmann, E.; Zeisel, M. B.; Baumert, T. F.; Keck, Z. Y.; Foung, S. K.; et al. Hepatitis C virus hypervariable region 1 modulates receptor interactions, conceals the CD81 binding site, and protects conserved neutralizing epitopes. J. Virol. 2010, 84, 5751-5763.
Prentoe, J.; Jensen, T. B.; Meuleman, P.; Serre, S. B.; Scheel, T. K.; Leroux-Roels, G.; Gottwein, J. M.; Bukh, J. Hypervariable region 1 differentially impacts viability of hepatitis C virus strains of genotypes 1 to 6 and impairs virus neutralization. J. Virol. 2011, 85, 2224-2234.
Feneant, L.; Levy, S.; Cocquerel, L. CD81 and hepatitis C virus (HCV) infection. Viruses 2014, 6, 535-572.
Charrin, S.; le Naour, F.; Silvie, O.; Milhiet, P. E.; Boucheix, C.; Rubinstein, E. Lateral organization of membrane proteins: Tetraspanins spin their web. BioChem. J. 2009, 420, 133-154.
Harris, H. J.; Clerte, C.; Farquhar, M. J.; Goodall, M.; Hu, K.; Rassam, P.; Dosset, P.; Wilson, G. K.; Balfe, P.; Ijzendoorn, S. C.; et al. Hepatoma polarization limits CD81 and hepatitis C virus dynamics. Cell. MicroBiol. 2013, 15, 430-445.
Potel, J.; Rassam, P.; Montpellier, C.; Kaestner, L.; Werkmeister, E.; Tews, B. A.; Couturier, C.; Popescu, C. I.; Baumert, T. F.; Rubinstein, E.; et al. EWI-2wint promotes CD81 clustering that abrogates hepatitis C virus entry. Cell. MicroBiol. 2013, 15, 1234-1252.
Kapadia, S. B.; Barth, H.; Baumert, T.; McKeating, J. A.; Chisari, F. V. Initiation of HCV infection is dependent on cholesterol and cooperativity between CD81 and scavenger receptor B type I. J. Virol. 2007, 81, 374-383.
Voisset, C.; Lavie, M.; Helle, F.; op de Beeck, A.; Bilheu, A.; Bertrand-Michel, J.; Tercé, F.; Cocquerel, L.; Wychowski, C.; Vu-Dac, N.; et al. Ceramide enrichment of the plasma membrane induces CD81 internalization and inhibits hepatitis C virus entry. Cell. MicroBiol. 2008, 10, 606-617.
Evans, M. J.; von Hahn, T.; Tscherne, D. M.; Syder, A. J.; Panis, M.; Wolk, B.; Hatziioannou, T.; McKeating, J. A.; Bieniasz, P. D.; Rice, C. M. Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry. Nature 2007, 446, 801-805.
Ploss, A.; Evans, M. J.; Gaysinskaya, V. A.; Panis, M.; You, H.; de Jong, Y. P.; Rice, C. M. Human occludin is a hepatitis C virus entry factor required for infection of mouse cells. Nature 2009, 457, 882-886.
Harris, H. J.; Davis, C.; Mullins, J. G.; Hu, K.; Goodall, M.; Farquhar, M. J.; Mee, C. J.; McCaffrey, K.; Young, S.; Drummer, H.; et al. Claudin association with CD81 defines hepatitis C virus entry. J. Biol. Chem. 2010, 285, 21092-21102.
Harris, H. J.; Farquhar, M. J.; Mee, C. J.; Davis, C.; Reynolds, G. M.; Jennings, A.; Hu, K.; Yuan, F.; Deng, H.; Hubscher, S. G.; et al. CD81 and claudin 1 coreceptor association: Role in hepatitis C virus entry. J. Virol. 2008, 82, 5007-5020.
Farquhar, M. J.; Hu, K.; Harris, H. J.; Davis, C.; Brimacombe, C. L.; Fletcher, S. J.; Baumert, T. F.; Rappoport, J. Z.; Balfe, P.; McKeating, J. A. Hepatitis C virus induces CD81 and claudin-1 endocytosis. J. Virol. 2012, 86, 4305-4316.
Dubuisson, J.; Cosset, F. L. Virology and cell biology of hepatitis C virus life cycle-An update. J. Hepatol 2014, 61, S3-S13.
Lupberger, J.; Zeisel, M. B.; Xiao, F.; Thumann, C.; Fofana, I.; Zona, L.; Davis, C.; Mee, C. J.; Turek, M.; Gorke, S.; et al. EGFR and EPHA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy. Nat. Med. 2011, 17, 589-595.
Zona, L.; Lupberger, J.; Sidahmed-Adrar, N.; Thumann, C.; Harris, H. J.; Barnes, A.; Florentin, J.; Tawar, R. G.; Xiao, F.; Turek, M.; et al. HRas signal transduction promotes hepatitis C virus cell entry by triggering assembly of the host tetraspanin receptor complex. Cell. Host Microbe 2013, 13, 302-313.
Sourisseau, M.; Michta, M. L.; Zony, C.; Israelow, B.; Hopcraft, S. E.; Narbus, C. M.; Parra Martin, A.; Evans, M. J. Temporal analysis of hepatitis C virus cell entry with occludin directed blocking antibodies. PLOS Pathog. 2013, 9, e1003244.
Benedicto, I.; Molina-Jimenez, F.; Bartosch, B.; Cosset, F. L.; Lavillette, D.; Prieto, J.; Moreno-Otero, R.; Valenzuela-Fernandez, A.; Aldabe, R.; Lopez-Cabrera, M.; et al. The tight junction-associated protein occludin is required for a postbinding step in hepatitis C virus entry and infection. J. Virol. 2009, 83, 8012-8020.
Liu, S.; Yang, W.; Shen, L.; Turner, J. R.; Coyne, C. B.; Wang, T. Tight junction proteins claudin-1 and occludin control hepatitis C virus entry and are downregulated during infection to prevent superinfection. J. Virol. 2009, 83, 2011-2014.
Sainz, B., Jr.; Barretto, N.; Martin, D. N.; Hiraga, N.; Imamura, M.; Hussain, S.; Marsh, K. A.; Yu, X.; Chayama, K.; Alrefai, W. A.; et al. Identification of the Niemann-Pick C1-like 1 cholesterol absorption receptor as a new hepatitis C virus entry factor. Nat. Med. 2012, 18, 281-285.
Blanchard, E.; Belouzard, S.; Goueslain, L.; Wakita, T.; Dubuisson, J.; Wychowski, C.; Rouille, Y. Hepatitis C virus entry depends on clathrin-mediated endocytosis. J. Virol. 2006, 80, 6964-6972.
Coller, K. E.; Berger, K. L.; Heaton, N. S.; Cooper, J. D.; Yoon, R.; Randall, G. RNA interference and single particle tracking analysis of hepatitis C virus endocytosis. PLOS Pathog. 2009, 5, e1000702.
Matsuda, M.; Suzuki, R.; Kataoka, C.; Watashi, K.; Aizaki, H.; Kato, N.; Matsuura, Y.; Suzuki, T.; Wakita, T. Alternative endocytosis pathway for productive entry of hepatitis C virus. J. Gen. Virol. 2014, 95, 2658-2667.
Sharma, N. R.; Mateu, G.; Dreux, M.; Grakoui, A.; Cosset, F. L.; Melikyan, G. B. Hepatitis C virus is primed by CD81 protein for low pH-dependent fusion. J. Biol. Chem. 2011, 286, 30361-30376.
Khan, A. G.; Whidby, J.; Miller, M. T.; Scarborough, H.; Zatorski, A. V.; Cygan, A.; Price, A. A.; Yost, S. A.; Bohannon, C. D.; Jacob, J.; et al. Structure of the core ectodomain of the hepatitis C virus envelope glycoprotein 2. Nature 2014, 509, 381-384.
Kong, L.; Giang, E.; Nieusma, T.; Kadam, R. U.; Cogburn, K. E.; Hua, Y.; Dai, X.; Stanfield, R. L.; Burton, D. R.; Ward, A. B.; et al. Hepatitis C virus E2 envelope glycoprotein core structure. Science 2013, 342, 1090-1094.
Krey, T.; d'Alayer, J.; Kikuti, C. M.; Saulnier, A.; Damier-Piolle, L.; Petitpas, I.; Johansson, D. X.; Tawar, R. G.; Baron, B.; Robert, B.; et al. The disulfide bonds in glycoprotein E2 of hepatitis C virus reveal the tertiary organization of the molecule. PLOS Pathog. 2010, 6, doi: 10. 1371/journal. ppat. 1000762.
Lavillette, D.; Pecheur, E. I.; Donot, P.; Fresquet, J.; Molle, J.; Corbau, R.; Dreux, M.; Penin, F.; Cosset, F. L. Characterization of fusion determinants points to the involvement of three discrete regions of both E1 and E2 glycoproteins in the membrane fusion process of hepatitis C virus. J. Virol. 2007, 81, 8752-8765.
Lohmann, V.; Korner, F.; Koch, J.; Herian, U.; Theilmann, L.; Bartenschlager, R. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 1999, 285, 110-113.
Egger, D.; Wölk, B.; Gosert, R.; Bianchi, L.; Blum, H. E.; Moradpour, D.; Bienz, K. Expression of hepatitis C virus proteins induces distinct membrane alterations including a candidate viral replication complex. J. Virol. 2002, 76, 5974-5984.
Gosert, R.; Egger, D.; Lohmann, V.; Bartenschlager, R.; Blum, H. E.; Bienz, K.; Moradpour, D. Identification of the hepatitis C virus RNA replication complex in Huh-7 cells harboring subgenomic replicons. J. Virol. 2003, 77, 5487-5492.
Rouille, Y.; Helle, F.; Delgrange, D.; Roingeard, P.; Voisset, C.; Blanchard, E.; Belouzard, S.; McKeating, J.; Patel, A. H.; Maertens, G.; et al. Subcellular localization of hepatitis C virus structural proteins in a cell culture system that efficiently replicates the virus. J. Virol. 2006, 80, 2832-2841.
Wolk, B.; Buchele, B.; Moradpour, D.; Rice, C. M. A dynamic view of hepatitis C virus replication complexes. J. Virol. 2008, 82, 10519-10531.
Ferraris, P.; Blanchard, E.; Roingeard, P. Ultrastructural and biochemical analyses of hepatitis C virus-associated host cell membranes. J. Gen. Virol. 2010, 91, 2230-2237.
Ferraris, P.; Beaumont, E.; Uzbekov, R.; Brand, D.; Gaillard, J.; Blanchard, E.; Roingeard, P. Sequential biogenesis of host cell membrane rearrangements induced by hepatitis C virus infection. Cell. Mol. Life Sci. 2013, 70, 1297-1306.
Romero-Brey, I.; Merz, A.; Chiramel, A.; Lee, J. Y.; Chlanda, P.; Haselman, U.; Santarella-Mellwig, R.; Habermann, A.; Hoppe, S.; Kallis, S.; et al. Three-dimensional architecture and biogenesis of membrane structures associated with hepatitis C virus replication. PLOS Pathog. 2012, 8, doi: 10. 1371/journal. ppat. 1003056.
Belov, G. A.; Nair, V.; Hansen, B. T.; Hoyt, F. H.; Fischer, E. R.; Ehrenfeld, E. Complex dynamic development of poliovirus membranous replication complexes. J. Virol. 2012, 86, 302-312.
Limpens, R. W.; van der Schaar, H. M.; Kumar, D.; Koster, A. J.; Snijder, E. J.; van Kuppeveld, F. J.; Barcena, M. The transformation of enterovirus replication structures: A three-dimensional study of single-and double-membrane compartments. MBio 2011, 2, doi: 10. 1128/mBio. 00166-11.
Knoops, K.; Kikkert, M.; Worm, S. H.; Zevenhoven-Dobbe, J. C.; van der Meer, Y.; Koster, A. J.; Mommaas, A. M.; Snijder, E. J. SARS-coronavirus replication is supported by a reticulovesicular network of modified endoplasmic reticulum. PLOS Biol. 2008, 6, doi: 10. 1371/journal. pbio. 0060226.
Ulasli, M.; Verheije, M. H.; de Haan, C. A.; Reggiori, F. Qualitative and quantitative ultrastructural analysis of the membrane rearrangements induced by coronavirus. Cell. MicroBiol. 2010, 12, 844-861.
Welsch, S.; Miller, S.; Romero-Brey, I.; Merz, A.; Bleck, C. K.; Walther, P.; Fuller, S. D.; Antony, C.; Krijnse-Locker, J.; Bartenschlager, R. Composition and three-dimensional architecture of the dengue virus replication and assembly sites. Cell. Host Microbe 2009, 5, 365-375.
Gillespie, L. K.; Hoenen, A.; Morgan, G.; Mackenzie, J. M. The endoplasmic reticulum provides the membrane platform for biogenesis of the flavivirus replication complex. J. Virol. 2010, 84, 10438-10447.
Schmeiser, S.; Mast, J.; Thiel, H. J.; Konig, M. Morphogenesis of pestiviruses: New insights from ultrastructural studies of strain giraffe-1. J. Virol. 2014, 88, 2717-2724.
Ivashkina, N.; Wolk, B.; Lohmann, V.; Bartenschlager, R.; Blum, H. E.; Penin, F.; Moradpour, D. The hepatitis C virus RNA-dependent RNA polymerase mambrane insertion sequence is a transmembrane segment. J. Virol. 2002, 76, 13088-13093.
Berger, K. L.; Cooper, J. D.; Heaton, N. S.; Yoon, R.; Oakland, T. E.; Jordan, T. X.; Mateu, G.; Grakoui, A.; Randall, G. Roles for endocytic trafficking and phosphatidylinositol 4-kinase III alpha in hepatitis C virus replication. Proc. Natl. Acad. Sci. USA 2009, 106, 7577-7582.
Stone, M.; Jia, S.; Heo, W. D.; Meyer, T.; Konan, K. V. Participation of rab5, an early endosome protein, in hepatitis C virus RNA replication machinery. J. Virol. 2007, 81, 4551-4563.
Tai, A. W.; Benita, Y.; Peng, L. F.; Kim, S. S.; Sakamoto, N.; Xavier, R. J.; Chung, R. T. A functional genomic screen identifies cellular cofactors of hepatitis C virus replication. Cell. Host Microbe 2009, 5, 298-307.
Shi, S. T.; Lee, K. J.; Aizaki, H.; Hwang, S. B.; Lai, M. M. Hepatitis C virus RNA replication occurs on a detergent-resistant membrane that cofractionates with caveolin-2. J. Virol. 2003, 77, 4160-4168.
Borawski, J.; Troke, P.; Puyang, X.; Gibaja, V.; Zhao, S.; Mickanin, C.; Leighton-Davies, J.; Wilson, C. J.; Myer, V.; Cornellataracido, I.; et al. Class III phosphatidylinositol 4-kinase alpha and beta are novel host factor regulators of hepatitis C virus replication. J. Virol. 2009, 83, 10058-10074.
Li, Q.; Brass, A. L.; Ng, A.; Hu, Z.; Xavier, R. J.; Liang, T. J.; Elledge, S. J. A genome-wide genetic screen for host factors required for hepatitis C virus propagation. Proc. Natl. Acad. Sci. USA 2009, 106, 16410-16415.
Trotard, M.; Lepere-Douard, C.; Regeard, M.; Piquet-Pellorce, C.; Lavillette, D.; Cosset, F. L.; Gripon, P.; Le Seyec, J. Kinases required in hepatitis C virus entry and replication highlighted by small interference RNA screening. FASEB J. 2009, 23, 3780-3789.
Vaillancourt, F. H.; Pilote, L.; Cartier, M.; Lippens, J.; Liuzzi, M.; Bethell, R. C.; Cordingley, M. G.; Kukolj, G. Identification of a lipid kinase as a host factor involved in hepatitis C virus RNA replication. Virology 2009, 387, 5-10.
Ahn, J.; Chung, K. S.; Kim, D. U.; Won, M.; Kim, L.; Kim, K. S.; Nam, M.; Choi, S. J.; Kim, H. C.; Yoon, M.; et al. Systematic identification of hepatocellular proteins interacting with NS5A of the hepatitis C virus. J. Biochem. Mol. Biol. 2004, 37, 741-748.
Berger, K. L.; Kelly, S. M.; Jordan, T. X.; Tartell, M. A.; Randall, G. Hepatitis C virus stimulates the phosphatidylinositol 4-kinase III alpha-dependent phosphatidylinositol 4-phosphate production that is essential for its replication. J. Virol. 2011, 85, 8870-8883.
Reiss, S.; Rebhan, I.; Backes, P.; Romero-Brey, I.; Erfle, H.; Matula, P.; Kaderali, L.; Poenisch, M.; Blankenburg, H.; Hiet, M. S.; et al. Recruitment and activation of a lipid kinase by hepatitis C virus NS5A is essential for integrity of the membranous replication compartment. Cell. Host Microbe 2011, 9, 32-45.
Leivers, A. L.; Tallant, M.; Shotwell, J. B.; Dickerson, S.; Leivers, M. R.; McDonald, O. B.; Gobel, J.; Creech, K. L.; Strum, S. L.; Mathis, A.; et al. Discovery of selective small molecule type III phosphatidylinositol 4-kinase alpha (PI4KIIIalpha) inhibitors as anti hepatitis C (HCV) agents. J. Med. Chem. 2014, 57, 2091-2106.
Bianco, A.; Reghellin, V.; Donnici, L.; Fenu, S.; Alvarez, R.; Baruffa, C.; Peri, F.; Pagani, M.; Abrignani, S.; Neddermann, P.; et al. Metabolism of phosphatidylinositol 4-kinase IIIalpha-dependent PI4P is subverted by HCV and is targeted by a 4-anilino quinazoline with antiviral activity. PLOS Pathog. 2012, 8, e1002576.
Lee, C.; Ma, H.; Hang, J. Q.; Leveque, V.; Sklan, E. H.; Elazar, M.; Klumpp, K.; Glenn, J. S. The hepatitis C virus NS5A inhibitor (BMS-790052) alters the subcellular localization of the NS5A non-structural viral protein. Virology 2011, 414, 10-18.
McGivern, D. R.; Masaki, T.; Williford, S.; Ingravallo, P.; Feng, Z.; Lahser, F.; Asante-Appiah, E.; Neddermann, P.; de Francesco, R.; Howe, A. Y.; et al. Kinetic analyses reveal potent and early blockade of hepatitis C virus assembly by NS5A inhibitors. Gastroenterology 2014, 147, 453. e7-462. e7.
Reghellin, V.; Donnici, L.; Fenu, S.; Berno, V.; Calabrese, V.; Pagani, M.; Abrignani, S.; Peri, F.; de Francesco, R.; Neddermann, P. NS5A inhibitors impair NS5A-PI4KIIIalpha complex formation and cause a decrease of PI4P and cholesterol levels in HCV-associated membranes. Antimicrob. Agents Chemother. 2014, doi: 10. 1128/AAC. 03293-14.
Targett-Adams, P.; Graham, E. J.; Middleton, J.; Palmer, A.; Shaw, S. M.; Lavender, H.; Brain, P.; Tran, T. D.; Jones, L. H.; Wakenhut, F.; et al. Small molecules targeting hepatitis C virus-encoded NS5A cause subcellular redistribution of their target: Insights into compound modes of action. J. Virol. 2011, 85, 6353-6368.
Hsu, N. Y.; Ilnytska, O.; Belov, G.; Santiana, M.; Chen, Y. H.; Takvorian, P. M.; Pau, C.; van der Schaar, H.; Kaushik-Basu, N.; Balla, T.; et al. Viral reorganization of the secretory pathway generates distinct organelles for RNA replication. Cell 2010, 141, 799-811.
Zhang, L.; Hong, Z.; Lin, W.; Shao, R. X.; Goto, K.; Hsu, V. W.; Chung, R. T. ARF1 and GBF1 generate a PI4P-enriched environment supportive of hepatitis C virus replication. PLOS ONE 2012, 7, doi: 10. 1371/journal. pone. 0032135.
Balla, T. Phosphoinositides: Tiny lipids with giant impact on cell regulation. Physiol. Rev. 2013, 93, 1019-1137.
Khan, I.; Katikaneni, D. S.; Han, Q.; Sanchez-Felipe, L.; Hanada, K.; Ambrose, R. L.; Mackenzie, J. M.; Konan, K. V. Modulation of hepatitis C virus genome replication by glycosphingolipids and four-phosphate adaptor protein 2. J. Virol. 2014, 88, 12276-12295.
Wang, H.; Perry, J. W.; Lauring, A. S.; Neddermann, P.; de Francesco, R.; Tai, A. W. Oxysterol-binding protein is a phosphatidylinositol 4-kinase effector required for HCV replication membrane integrity and cholesterol trafficking. Gastroenterology 2014, 146, doi: 10. 1053/j. gastro. 2014. 02. 002.
Mesmin, B.; Bigay, J.; Moser von Filseck, J.; Lacas-Gervais, S.; Drin, G.; Antonny, B. A four-step cycle driven by PI(4)P hydrolysis directs sterol/PI(4)P exchange by the ER-Golgi tether OSBP. Cell 2013, 155, 830-843.
Gao, L.; Aizaki, H.; He, J. W.; Lai, M. M. Interactions between viral nonstructural proteins and host protein hVAP-33 mediate the formation of hepatitis C virus RNA replication complex on lipid raft. J. Virol. 2004, 78, 3480-3488.
Matto, M.; Sklan, E. H.; David, N.; Melamed-Book, N.; Casanova, J. E.; Glenn, J. S.; Aroeti, B. Role for ADP ribosylation factor 1 in the regulation of hepatitis C virus replication. J. Virol. 2011, 85, 946-956.
Arita, M.; Kojima, H.; Nagano, T.; Okabe, T.; Wakita, T.; Shimizu, H. Phosphatidylinositol 4-kinase III beta is a target of enviroxime-like compounds for antipoliovirus activity. J. Virol. 2011, 85, 2364-2372.
Arita, M. Phosphatidylinositol-4 kinase III beta and oxysterol-binding protein accumulate unesterified cholesterol on poliovirus-induced membrane structure. Microbiol. Immunol. 2014, 58, 239-256.
Amako, Y.; Sarkeshik, A.; Hotta, H.; Yates, J., 3rd; Siddiqui, A. Role of oxysterol binding protein in hepatitis C virus infection. J. Virol. 2009, 83, 9237-9246.
D'Angelo, G.; Polishchuk, E.; di Tullio, G.; Santoro, M.; di Campli, A.; Godi, A.; West, G.; Bielawski, J.; Chuang, C. C.; van der Spoel, A. C.; et al. Glycosphingolipid synthesis requires FAPP2 transfer of glucosylceramide. Nature 2007, 449, 62-67.
Diamond, D. L.; Syder, A. J.; Jacobs, J. M.; Sorensen, C. M.; Walters, K. A.; Proll, S. C.; McDermott, J. E.; Gritsenko, M. A.; Zhang, Q.; Zhao, R.; et al. Temporal proteome and lipidome profiles reveal hepatitis C virus-associated reprogramming of hepatocellular metabolism and bioenergetics. PLOS Pathog. 2010, 6, doi: 10. 1371/journal. ppat. 1000719.
Kapadia, S. B.; Chisari, F. V. Hepatitis C virus rna replication is regulated by host geranylgeranylation and fatty acids. Proc. Natl. Acad. Sci. USA 2005, 102, 2561-2566.
Su, A. I.; Pezacki, J. P.; Wodicka, L.; Brideau, A. D.; Supekova, L.; Thimme, R.; Wieland, S.; Bukh, J.; Purcell, R. H.; Schultz, P. G.; et al. Genomic analysis of the host response to hepatitis C virus infection. Proc. Natl. Acad. Sci. USA 2002, 99, 15669-15674.
Waris, G.; Felmlee, D. J.; Negro, F.; Siddiqui, A. Hepatitis C virus induces proteolytic cleavage of sterol regulatory element binding proteins and stimulates their phosphorylation via oxidative stress. J. Virol. 2007, 81, 8122-8130.
Olmstead, A. D.; Knecht, W.; Lazarov, I.; Dixit, S. B.; Jean, F. Human subtilase SKI-1/S1P is a master regulator of the HCV lifecycle and a potential host cell target for developing indirect-acting antiviral agents. PLOS Pathog. 2012, 8, e1002468.
Nasheri, N.; Joyce, M.; Rouleau, Y.; Yang, P.; Yao, S.; Tyrrell, D. L.; Pezacki, J. P. Modulation of fatty acid synthase enzyme activity and expression during hepatitis C virus replication. Chem. Biol. 2013, 20, 570-582.
Yang, W.; Hood, B. L.; Chadwick, S. L.; Liu, S.; Watkins, S. C.; Luo, G.; Conrads, T. P.; Wang, T. Fatty acid synthase is up-regulated during hepatitis C virus infection and regulates hepatitis C virus entry and production. Hepatology 2008, 48, 1396-1403.
Lyn, R. K.; Singaravelu, R.; Kargman, S.; O'Hara, S.; Chan, H.; Oballa, R.; Huang, Z.; Jones, D. M.; Ridsdale, A.; Russell, R. S.; et al. Stearoyl-CoA desaturase inhibition blocks formation of hepatitis C virus-induced specialized membranes. Sci. Rep. 2014, 4, doi: 10. 1038/srep04549.
Nguyen, L. N.; Lim, Y. S.; Pham, L. V.; Shin, H. Y.; Kim, Y. S.; Hwang, S. B. Stearoyl coenzyme A desaturase 1 is associated with hepatitis C virus replication complex and regulates viral replication. J. Virol. 2014, 88, 12311-12325.
Rasmussen, A. L.; Diamond, D. L.; McDermott, J. E.; Gao, X.; Metz, T. O.; Matzke, M. M.; Carter, V. S.; Belisle, S. E.; Korth, M. J.; Waters, K. M.; et al. Systems virology identifies a mitochondrial fatty acid oxidation enzyme, dodecenoyl coenzyme A delta isomerase, required for hepatitis C virus replication and likely pathogenesis. J. Virol. 2011, 85, 11646-11654.
Majeau, N.; Fromentin, R.; Savard, C.; Duval, M.; Tremblay, M. J.; Leclerc, D. Palmitoylation of hepatitis C virus core protein is important for virion production. J. Biol. Chem. 2009, 284, 33915-33925.
Yu, G. Y.; Lee, K. J.; Gao, L.; Lai, M. M. Palmitoylation and polymerization of hepatitis C virus NS4B protein. J. Virol. 2006, 80, 6013-6023.
Chao, T. C.; Su, W. C.; Huang, J. Y.; Chen, Y. C.; Jeng, K. S.; Wang, H. D.; Lai, M. M. Proline-serine-threonine phosphatase-interacting protein 2 (PSTPIP2), a host membrane-deforming protein, is critical for membranous web formation in hepatitis C virus replication. J. Virol. 2012, 86, 1739-1749.
Xu, S.; Pei, R.; Guo, M.; Han, Q.; Lai, J.; Wang, Y.; Wu, C.; Zhou, Y.; Lu, M.; Chen, X. Cytosolic phospholipase A2 gamma is involved in hepatitis C virus replication and assembly. J. Virol. 2012, 86, 13025-13037.
Hirata, Y.; Ikeda, K.; Sudoh, M.; Tokunaga, Y.; Suzuki, A.; Weng, L.; Ohta, M.; Tobita, Y.; Okano, K.; Ozeki, K.; et al. Self-enhancement of hepatitis C virus replication by promotion of specific sphingolipid biosynthesis. PLOS Pathog. 2012, 8, e1002860.
Katsume, A.; Tokunaga, Y.; Hirata, Y.; Munakata, T.; Saito, M.; Hayashi, H.; Okamoto, K.; Ohmori, Y.; Kusanagi, I.; Fujiwara, S.; et al. A serine palmitoyltransferase inhibitor blocks hepatitis C virus replication in human hepatocytes. Gastroenterology 2013, 145, 865-873.
Sakamoto, H.; Okamoto, K.; Aoki, M.; Kato, H.; Katsume, A.; Ohta, A.; Tsukuda, T.; Shimma, N.; Aoki, Y.; Arisawa, M.; et al. Host sphingolipid biosynthesis as a target for hepatitis C virus therapy. Nat. Chem. Biol. 2005, 1, 333-337.
Huang, H.; Chen, Y.; Ye, J. Inhibition of hepatitis C virus replication by peroxidation of arachidonate and restoration by vitamin E. Proc. Natl. Acad. Sci. USA 2007, 104, 18666-18670.
Pollock, S.; Nichita, N. B.; Bohmer, A.; Radulescu, C.; Dwek, R. A.; Zitzmann, N. Polyunsaturated liposomes are antiviral against hepatitis B and C viruses and hiv by decreasing cholesterol levels in infected cells. Proc. Natl. Acad. Sci. USA 2010, 107, 17176-17181.
Yamane, D.; McGivern, D. R.; Wauthier, E.; Yi, M.; Madden, V. J.; Welsch, C.; Antes, I.; Wen, Y.; Chugh, P. E.; McGee, C. E.; et al. Regulation of the hepatitis C virus RNA replicase by endogenous lipid peroxidation. Nat. Med. 2014, 20, 927-935.
Goueslain, L.; Alsaleh, K.; Horellou, P.; Roingeard, P.; Descamps, V.; Duverlie, G.; Ciczora, Y.; Wychowski, C.; Dubuisson, J.; Rouille, Y. Identification of GBF1 as a cellular factor required for hepatitis C virus RNA replication. J. Virol. 2010, 84, 773-787.
Belov, G. A.; Feng, Q.; Nikovics, K.; Jackson, C. L.; Ehrenfeld, E. A critical role of a cellular membrane traffic protein in poliovirus RNA replication. PLOS Pathog. 2008, 4, e1000216.
Lanke, K. H.; van der Schaar, H. M.; Belov, G. A.; Feng, Q.; Duijsings, D.; Jackson, C. L.; Ehrenfeld, E.; van Kuppeveld, F. J. GBF1, a guanine nucleotide exchange factor for Arf, is crucial for coxsackievirus B3 RNA replication. J. Virol. 2009, 83, 11940-11949.
Verheije, M. H.; Raaben, M.; Mari, M.; te Lintelo, E. G.; Reggiori, F.; van Kuppeveld, F. J.; Rottier, P. J.; de Haan, C. A. Mouse hepatitis coronavirus RNA replication depends on GBF1-mediated ARF1 activation. PLOS Pathog. 2008, 4, e1000088.
Carpp, L. N.; Rogers, R. S.; Moritz, R. L.; Aitchison, J. D. Quantitative proteomic analysis of host-virus interactions reveals a role for GBF1 in dengue infection. Mol. Cell. Proteom. 2014, 13, 2836-2854.
Donaldson, J. G.; Jackson, C. L. ARF family G proteins and their regulators: Roles in membrane transport, development and disease. Nat. Rev. Mol. Cell. Biol. 2011, 12, 362-375.
Wright, J.; Kahn, R. A.; Sztul, E. Regulating the large Sec7 ARF guanine nucleotide exchange factors: The when, where and how of activation. Cell. Mol. Life Sci. 2014, 71, 3419-3438.
Cherry, S.; Kunte, A.; Wang, H.; Coyne, C.; Rawson, R. B.; Perrimon, N. COPI activity coupled with fatty acid biosynthesis is required for viral replication. PLOS Pathog. 2006, 2, e102.
Gazina, E. V.; Mackenzie, J. M.; Gorrell, R. J.; Anderson, D. A. Differential requireents for COPI coats in formation of replication complexes among three genera of picornaviridae. J. Virol. 2002, 76, 11113-11122.
Farhat, R.; Goueslain, L.; Wychowski, C.; Belouzard, S.; Feneant, L.; Jackson, C. L.; Dubuisson, J.; Rouille, Y. Hepatitis C virus replication and Golgi function in brefeldin A-resistant hepatoma-derived cells. PLOS ONE 2013, 8, e74491.
Ellong, E. N.; Soni, K. G.; Bui, Q. T.; Sougrat, R.; Golinelli-Cohen, M. P.; Jackson, C. L. Interaction between the triglyceride lipase ATGL and the Arf1 activator GBF1. PLOS ONE 2011, 6, e21889.
Beller, M.; Sztalryd, C.; Southall, N.; Bell, M.; Jackle, H.; Auld, D. S.; Oliver, B. Copi complex is a regulator of lipid homeostasis. PLOS Biol. 2008, 6, e292.
Guo, Y.; Walther, T. C.; Rao, M.; Stuurman, N.; Goshima, G.; Terayama, K.; Wong, J. S.; Vale, R. D.; Walter, P.; Farese, R. V. Functional genomic screen reveals genes involved in lipid-droplet formation and utilization. Nature 2008, 453, 657-661.
Li, H.; Yang, X.; Yang, G.; Hong, Z.; Zhou, L.; Yin, P.; Xiao, Y.; Chen, L.; Chung, R. T.; Zhang, L. Hepatitis C virus NS5A hijacks ARFGAP1 to maintain a phosphatidylinositol 4-phosphate-enriched microenvironment. J. Virol. 2014, 88, 5956-5966.
Belov, G. A.; Kovtunovych, G.; Jackson, C. L.; Ehrenfeld, E. Poliovirus replication requires the N-terminus but not the catalytic sec7 domain of ARFGEF GBF1. Cell. MicroBiol. 2010, 12, 1463-1479.
Murray, C. L.; Jones, C. T.; Rice, C. M. Architects of assembly: Roles of Flaviviridae non-structural proteins in virion morphogenesis. Nat. Rev. MicroBiol. 2008, 6, 699-708.
Miyanari, Y.; Atsuzawa, K.; Usuda, N.; Watashi, K.; Hishiki, T.; Zayas, M.; Bartenschlager, R.; Wakita, T.; Hijikata, M.; Shimotohno, K. The lipid droplet is an important organelle for hepatitis C virus production. Nat. Cell. Biol. 2007, 9, 1089-1097.
Liefhebber, J. M.; Hague, C. V.; Zhang, Q.; Wakelam, M. J.; McLauchlan, J. Modulation of triglyceride and cholesterol ester synthesis impairs assembly of infectious hepatitis C virus. J. Biol. Chem. 2014, 289, 21276-21288.
Pol, A.; Gross, S. P.; Parton, R. G. Review: Biogenesis of the multifunctional lipid droplet: Lipids, proteins, and sites. J. Cell. Biol. 2014, 204, 635-646.
Welte, M. A. Fat on the move: Intracellular motion of lipid droplets. BioChem. Soc. Trans. 2009, 37, 991-996.
Bartz, R.; Zehmer, J. K.; Zhu, M.; Chen, Y.; Serrero, G.; Zhao, Y.; Liu, P. Dynamic activity of lipid droplets: Protein phosphorylation and GTP-mediated protein translocation. J. Proteome Res. 2007, 6, 3256-3265.
Marcinkiewicz, A.; Gauthier, D.; Garcia, A.; Brasaemle, D. L. The phosphorylation of serine 492 of perilipin a directs lipid droplet fragmentation and dispersion. J. Biol. Chem. 2006, 281, 11901-11909.
Boulant, S.; Vanbelle, C.; Ebel, C.; Penin, F.; Lavergne, J. P. Hepatitis C virus core protein is a dimeric alpha-helical protein exhibiting membrane protein features. J. Virol. 2005, 79, 11353-11365.
Boulant, S.; Montserret, R.; Hope, G.; Ratinier, M.; Targett-Adams, P.; Lavergne, J. P.; Penin, F.; McLauchlan, J. Structural determinants that target the hepatitis C virus core protein to lipid droplets. J. Biol. Chem. 2006, 281, 22236-22247.
Jirasko, V.; Montserret, R.; Lee, J. Y.; Gouttenoire, J.; Moradpour, D.; Penin, F.; Bartenschlager, R. Structural and functional studies of nonstructural protein 2 of the hepatitis C virus reveal its key role as organizer of virion assembly. PLOS Pathog. 2010, 6, e1001233.
Popescu, C. I.; Callens, N.; Trinel, D.; Roingeard, P.; Moradpour, D.; Descamps, V.; Duverlie, G.; Penin, F.; Heliot, L.; Rouille, Y.; et al. NS2 protein of hepatitis C virus interacts with structural and non-structural proteins towards virus assembly. PLOS Pathog. 2011, 7, e1001278.
Tellinghuisen, T. L.; Marcotrigiano, J.; Rice, C. M. Structure of the zinc-binding domain of an essential component of the hepatitis C virus replicase. Nature 2005, 435, 374-379.
Huang, L.; Hwang, J.; Sharma, S. D.; Hargittai, M. R.; Chen, Y.; Arnold, J. J.; Raney, K. D.; Cameron, C. E. Hepatitis C virus nonstructural protein 5A (NS5A) is an RNA-binding protein. J. Biol. Chem. 2005, 280, 36417-36428.
Appel, N.; Zayas, M.; Miller, S.; Krijnse-Locker, J.; Schaller, T.; Friebe, P.; Kallis, S.; Engel, U.; Bartenschlager, R. Essential role of domain III of nonstructural protein 5A for hepatitis C virus infectious particle assembly. PLOS Pathog. 2008, 4, e1000035.
Tanji, Y.; Kaneko, T.; Satoh, S.; Shimotohno, K. Phosphorylation of hepatitis C virus-encoded nonstructural protein NS5A. J. Virol. 1995, 69, 3980-3986.
Tellinghuisen, T. L.; Foss, K. L.; Treadaway, J. Regulation of hepatitis C virion production via phosphorylation of the NS5A protein. PLOS Pathog. 2008, 4, e1000032.
Masaki, T.; Suzuki, R.; Murakami, K.; Aizaki, H.; Ishii, K.; Murayama, A.; Date, T.; Matsuura, Y.; Miyamura, T.; Wakita, T.; et al. Interaction of hepatitis C virus nonstructural protein 5A with core protein is critical for the production of infectious virus particles. J. Virol. 2008, 82, 7964-7976.
Boulant, S.; Douglas, M. W.; Moody, L.; Budkowska, A.; Targett-Adams, P.; McLauchlan, J. Hepatitis C virus core protein induces lipid droplet redistribution in a microtubule-and dynein-dependent manner. Traffic 2008, 9, 1268-1282.
Counihan, N. A.; Rawlinson, S. M.; Lindenbach, B. D. Trafficking of hepatitis C virus core protein during virus particle assembly. PLOS Pathog. 2011, 7, e1002302.
Boson, B.; Granio, O.; Bartenschlager, R.; Cosset, F. L. A concerted action of hepatitis C virus p7 and nonstructural protein 2 regulates core localization at the endoplasmic reticulum and virus assembly. PLOS Pathog. 2011, 7, e1002144.
Shavinskaya, A.; Boulant, S.; Penin, F.; McLauchlan, J.; Bartenschlager, R. The lipid droplet binding domain of hepatitis C virus core protein is a major determinant for efficient virus assembly. J. Biol. Chem. 2007, 282, 37158-37169.
Coller, K. E.; Heaton, N. S.; Berger, K. L.; Cooper, J. D.; Saunders, J. L.; Randall, G. Molecular determinants and dynamics of hepatitis C virus secretion. PLOS Pathog. 2012, 8, e1002466.
Herker, E.; Harris, C.; Hernandez, C.; Carpentier, A.; Kaehlcke, K.; Rosenberg, A. R.; Farese, R. V., Jr.; Ott, M. Efficient hepatitis C virus particle formation requires diacylglycerol acyltransferase-1. Nat. Med. 2010, 16, 1295-1298.
Li, Q.; Pene, V.; Krishnamurthy, S.; Cha, H.; Liang, T. J. Hepatitis C virus infection activates an innate pathway involving IKK-alpha in lipogenesis and viral assembly. Nat. Med. 2013, 19, 722-729.
Menzel, N.; Fischl, W.; Hueging, K.; Bankwitz, D.; Frentzen, A.; Haid, S.; Gentzsch, J.; Kaderali, L.; Bartenschlager, R.; Pietschmann, T. Map-kinase regulated cytosolic phospholipase A2 activity is essential for production of infectious hepatitis C virus particles. PLOS Pathog. 2012, 8, e1002829.
Nevo-Yassaf, I.; Yaffe, Y.; Asher, M.; Ravid, O.; Eizenberg, S.; Henis, Y. I.; Nahmias, Y.; Hirschberg, K.; Sklan, E. H. Role for TBC1D20 and rab1 in hepatitis C virus replication via interaction with lipid droplet-bound nonstructural protein 5A. J. Virol. 2012, 86, 6491-6502.
Masaki, T.; Matsunaga, S.; Takahashi, H.; Nakashima, K.; Kimura, Y.; Ito, M.; Matsuda, M.; Murayama, A.; Kato, T.; Hirano, H.; et al. Involvement of hepatitis C virus NS5A hyperphosphorylation mediated by casein kinase I-alpha in infectious virus production. J. Virol. 2014, 88, 7541-7555.
Evans, M. J.; Rice, C. M.; Goff, S. P. Phosphorylation of hepatitis C virus nonstructural protein 5A modulates its protein interactions and viral RNA replication. Proc. Natl. Acad. Sci. USA 2004, 101, 13038-13043.
Salloum, S.; Wang, H.; Ferguson, C.; Parton, R. G.; Tai, A. W. Rab18 binds to hepatitis C virus NS5A and promotes interaction between sites of viral replication and lipid droplets. PLOS Pathog. 2013, 9, e1003513.
Camus, G.; Herker, E.; Modi, A. A.; Haas, J. T.; Ramage, H. R.; Farese, R. V., Jr.; Ott, M. Diacylglycerol acyltransferase-1 localizes hepatitis C virus NS5A protein to lipid droplets and enhances NS5A interaction with the viral capsid core. J. Biol. Chem. 2013, 288, 9915-9923.
Benga, W. J.; Krieger, S. E.; Dimitrova, M.; Zeisel, M. B.; Parnot, M.; Lupberger, J.; Hildt, E.; Luo, G.; McLauchlan, J.; Baumert, T. F.; et al. Apolipoprotein E interacts with hepatitis C virus nonstructural protein 5A and determines assembly of infectious particles. Hepatology 2010, 51, 43-53.
Cun, W.; Jiang, J.; Luo, G. The C-terminal alpha-helix domain of apolipoprotein E is required for interaction with nonstructural protein 5A and assembly of hepatitis C virus. J. Virol. 2010, 84, 11532-11541.
Backes, P.; Quinkert, D.; Reiss, S.; Binder, M.; Zayas, M.; Rescher, U.; Gerke, V.; Bartenschlager, R.; Lohmann, V. Role of annexin A2 in the production of infectious hepatitis C virus particles. J. Virol. 2010, 84, 5775-5789.
Lindenbach, B. D.; Rice, C. M. The ins and outs of hepatitis C virus entry and assembly. Nat. Rev. MicroBiol. 2013, 11, 688-700.
Ma, Y.; Anantpadma, M.; Timpe, J. M.; Shanmugam, S.; Singh, S. M.; Lemon, S. M.; Yi, M. Hepatitis C virus NS2 protein serves as a scaffold for virus assembly by interacting with both structural and nonstructural proteins. J. Virol. 2011, 85, 86-97.
Stapleford, K. A.; Lindenbach, B. D. Hepatitis C virus NS2 coordinates virus particle assembly through physical interactions with the E1-E2 glycoprotein and NS3-NS4A enzyme complexes. J. Virol. 2011, 85, 1706-1717.
Suzuki, R.; Matsuda, M.; Watashi, K.; Aizaki, H.; Matsuura, Y.; Wakita, T.; Suzuki, T. Signal peptidase complex subunit 1 participates in the assembly of hepatitis C virus through an interaction with E2 and NS2. PLOS Pathog. 2013, 9, e1003589.
Bishe, B.; Syed, G. H.; Field, S. J.; Siddiqui, A. Role of phosphatidylinositol 4-phosphate (PI4P) and its binding protein GOLPH3 in hepatitis C virus secretion. J. Biol. Chem. 2012, 287, 27637-27647.
Li, X.; Jiang, H.; Qu, L.; Yao, W.; Cai, H.; Chen, L.; Peng, T. Hepatocyte nuclear factor 4alpha and downstream secreted phospholipase A2 GXIIB regulate production of infectious hepatitis C virus. J. Virol. 2014, 88, 612-627.
Parent, R.; Qu, X.; Petit, M. A.; Beretta, L. The heat shock cognate protein 70 is associated with hepatitis C virus particles and modulates virus infectivity. Hepatology 2009, 49, 1798-1809.
Huang, H.; Sun, F.; Owen, D. M.; Li, W.; Chen, Y.; Gale, M., Jr.; Ye, J. Hepatitis c virus production by human hepatocytes dependent on assembly and secretion of very low-density lipoproteins. Proc. Natl. Acad. Sci. USA 2007, 104, 5848-5853.
Da Costa, D.; Turek, M.; Felmlee, D. J.; Girardi, E.; Pfeffer, S.; Long, G.; Bartenschlager, R.; Zeisel, M. B.; Baumert, T. F. Reconstitution of the entire hepatitis C virus life cycle in nonhepatic cells. J. Virol. 2012, 86, 11919-11925.
Hueging, K.; Doepke, M.; Vieyres, G.; Bankwitz, D.; Frentzen, A.; Doerrbecker, J.; Gumz, F.; Haid, S.; Wolk, B.; Kaderali, L.; et al. Apolipoprotein E codetermines tissue tropism of hepatitis C virus and is crucial for viral cell-to-cell transmission by contributing to a postenvelopment step of assembly. J. Virol. 2014, 88, 1433-1446.
